Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation

Abraham Z. Reznick(BioEnergetics (United States)), C E Cross(University of California Davis Medical Center), Miao‐Lin Hu(University of California Davis Medical Center), Yuichiro Suzuki(BioEnergetics (United States)), Shamsuddin Khwaja(BioEnergetics (United States)), Asaad Safadi(BioEnergetics (United States)), Paul A. Motchnik(University of California, Berkeley), Lester Packer(BioEnergetics (United States)), Barry Halliwell(University of California Davis Medical Center)
Biochemical Journal
September 1, 1992
Cited by 274Open Access
Full Text

Abstract

Exposure of human plasma to gas-phase (but not to whole) cigarette smoke (CS) produces oxidative damage to lipids [Frei, Forte, Ames & Cross (1991) Biochem. J. 277, 133-138], which is prevented by ascorbic acid. The ability of CS to induce protein damage was measured by the carbonyl assay and by loss of enzyme activity and protein -SH groups. Both whole and gas-phase CS caused formation of carbonyls in human plasma, which was partially inhibited by GSH but not by ascorbic acid or metal-ion-chelating agents. Isolated albumin exposed to CS showed much faster carbonyl formation (per unit protein) than did whole plasma; damage to isolated albumin was partially prevented by chelating agents. Isolated creatine kinase (CK) lost activity upon exposure to CS much faster than did CK in plasma. Direct addition to plasma of mixtures of some or all of the aldehydes reported to be present in CS caused protein carbonyl formation and inactivation of CK, but neither occurred to the extent produced by CS exposure.


Related Papers

No related papers found

Powered by citation graph analysis